Find a Clinical Trial
Filter
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
Evaluation of BE1116 (4F-PCC) in patients with traumatic injury and confirmed or suspected acute major bleeding to improve survival
Trauma
All genders
15+
Recruiting now
Department of Surgery, Division of Trauma
TAP Block and minimally invasive hysterectomy for pain control
Uterine cancer
Female
18-80
Recruiting now
Department of Obstetrics + Gynecology
Feasibility of a new method for non-invasive monitoring of low-grade bladder cancer
Bladder cancer
All genders
18-90
Recruiting now
Department of Urology
Multi-spectral imaging
Ovarian cancer
Female
18-99
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Non- Invasive, Label-free Detection of Cervical Pre-Cancers In vivo
Cervical cancer
All genders
18-100
Recruiting now
Department of Obstetrics + Gynecology
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma (XPORT-EC-042)
Endometrial cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center